Role of physiologically based biopharmaceutics modeling in predicting and circumventing the drug-drug interactions of tyrosine kinase inhibitors with acid-reducing agents
Sivacharan Kollipara, Praveen Sivadasu, S. R. Rashmi, Punna Rao Ravi, Chakravarthi Guntupalli
DOI: 10.7324/JAPS.2025.234298Pages: 055-069
Model integrated evidence approach for rational and safe formulation development: case of alfuzosin prolonged-release tablets
Sivacharan Kollipara, Rajkumar Boddu, Suribabu Bonda, Hariharan Venugopal, Chandra Deb, Pavan Kumar Mittapalli, Anand Arumugam, Sohel Mohammed Khan, Venkat Ramana Naidu
DOI: 10.7324/JAPS.2025.231215Pages: 253-264
_.webp)